Called Velo, the system can perform true PCR testing in 10 minutes or less and is intended for use in decentralized spaces.

A new study found that women who received mail-in self-collection kits participated in screening at much higher rates than those who just received a telephone reminder.

The firm is maintaining its full-year guidance and expects to make the acquisition once Lex Diagnostics obtains 510(k) clearance of its system.

The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.

The RiskReveal assay was used to determine which early-stage non-squamous NSCLC patients should undergo adjuvant chemotherapy ...

The partners will work together to explore the use of a technology from Fujirebio subsidiary Fluxus in infectious disease.

The Randox ConcizuTrace ELISA is used to determine the concentration in blood of Novo Nordisk's Alhemo (concizumab-mtci) to aid dose adjustments.

NEW YORK – Danaher subsidiary Cepheid announced Wednesday that its Xpert HIV-1 Viral Load XC assay has received a medical device license from Health Canada. The next-generation extended coverage test ...

Company officials disclosed that it had been eyeing an out from Savanna in the potential acquisition of Lex Diagnostics for at least the past 18 months.

CHICAGO – A team of researchers from Memorial Sloan Kettering Cancer Center has developed a Pap-based assay for endometrial cancer that is able to detect higher amounts of cell-free DNA than blood ...

The recommendations, contained in a report to Congress, follow the GAO's inclusion of the HHS on its High-Risk List of government operations due to "persistent deficiencies in [its] ability to perform ...

NEW YORK – QuidelOrtho announced after the close of the market on Tuesday that it will discontinue development of its Savanna molecular diagnostic system and that it aims to acquire UK-based Lex ...